Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on March 24, 2025
Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 24, 2025
– Continued progress in pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) toward first subject treated, on track to take place in the first quarter of 2025 – Multiple subjects currently being screened in first MIRACLE site activated – Initial …
Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
GlobeNewswire
·
March 24, 2025
- Suprachoroidal Delivery Develops as Promising Mainstream Procedure for Treating Multiple Macular Diseases - - SCS Microinjector® Provides Targeted and Compartmentalized Delivery of Therapeutics Directly to the Retina - ALPHARETTA, Ga., March 24, 2025 ( …
Mitolyn Weight Loss (EXPOSED) Buyers Unexpected Insights Reports 2025
GlobeNewswire
·
March 24, 2025
TALLMADGE, Ohio, March 24, 2025 (GLOBE NEWSWIRE) -- The prime cause for weight gain is seen to be predominantly because of the presence of a superfluous amount of white fats in the body which aids in the increment of the stored calories of the body. The …
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
GlobeNewswire
·
March 24, 2025
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidence interval), but did not meet statistical non- …
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
GlobeNewswire
·
March 24, 2025
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025 ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia ( …
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
GlobeNewswire
·
March 24, 2025
EXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 years of commercial leadership, business development, and strategic sales operations …
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food …
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
GlobeNewswire
·
March 24, 2025
Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity and Urothelial Field Effect Favorable Safety Profile; Only Grade 1 Drug-Related Adverse Events …
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
March 24, 2025
– Company on track to initiate ELEVATE-45-201 study in Q3 2025 – – ELEVATE-45 regulatory filings submitted in the EU, with regulatory review ongoing – – ELEVATE-45 is the second of three novel exon skipping Duchenne programs the Company expects to …
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
GlobeNewswire
·
March 24, 2025
CAMBRIDGE, Massachusetts, March 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins …
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
GlobeNewswire
·
March 24, 2025
Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI across participants with abnormal LVMI at baseline, frataxin expression to be evaluated for any increase from …
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
GlobeNewswire
·
March 24, 2025
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two key measures of antiviral activity in preclinical bird flu models Results build on earlier positive findings of …
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced the …
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 24, 2025
FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval FDA recommended measuring skin FXN concentrations …
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
GlobeNewswire
·
March 24, 2025
REHOVOT, Israel and HOBOKEN, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the …
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
GlobeNewswire
·
March 24, 2025
Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., …
Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail
GlobeNewswire
·
March 24, 2025
Tilray Expands Their Health-Focused Food and Beverage Portfolio with the Reintroduction of a Beloved Energy Drink, Hi*Ball Energy NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Tilray Wellness, the better-for-you food and beverage division of Tilray Brands, …
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
GlobeNewswire
·
March 24, 2025
-- Conference taking place on March 27-29, 2025 in New Orleans -- -- CAGLA NeauxCancer Conference is a leading global forum in oncology -- MIAMI, March 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a …
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
GlobeNewswire
·
March 24, 2025
HUNTSVILLE, AL, March 24, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, announced that Randall Moreadith, M.D., …
NativePath Native Hydrate: The Senior Hydration Solution That Supports Energy, Bladder Health & Brain Function
GlobeNewswire
·
March 24, 2025
MIAMI, March 24, 2025 (GLOBE NEWSWIRE) -- Maintaining proper hydration is more crucial than ever in today's fast-paced world, especially for individuals over 60. Dehydration can lead to a host of health issues, including weakened bladder control, cognitive …